B61 (ephrin-A1), a ligand for eph receptor-protein tyrosine kinases, possesses angiogenic and endothelial cell chemoattractant activity. We report the expression profile of ephrin-A1 during mouse embryogenesis (7.25 to 10.5 days post-coitum (dpc)). Ephrin-A1 expression was first detected in the caudal end of the primitive streak and the developing allantois. At mid head fold stage, ephrin-A1 transcripts were observed in the anterior pharyngeal endoderm that underlies the site of the future heart. In 8.0 to 8.5 dpc embryos, ephrin-A1 was expressed in presumptive endocardial cells, the dorsal aorta, and the primary head veins. In 9.5 to 10.5 dpc embryos, ephrin-A1 RNA was detected in intersomitic vessels and the limb bud vasculature. Each site of ephrin-A1 expression corresponded to regions of vasculogenesis and/or angiogenesis.
Ephrin-A1 is an immediate-early response gene of endothelium induced by TNF-a (Holzman et al., 1990) that possesses angiogenic and endothelial cell chemoattractant activity (Pandey et al., 1995) . Ephrins are cell membrane-associated proteins (Flanagan and Vanderhaeghen, 1998 ) that activate eph receptor-protein tyrosine kinases. Eph signaling pathways have been shown to function in the repulsive guidance of retinal axons, trunk neural crest, and in hindbrain segmentation (Flanagan and Vanderhaeghen, 1998) .
Ephrin-B2 knockout mice have been shown to have defects in angiogenesis (Wang et al., 1998) . Ephrin-B2 was shown to exhibit arterial-specific expression, while its receptor eph-B4 exhibited vein-specific expression. In human renal microvascular endothelial cells, ephrin-B1 promoted capillary-like assembly (Stein et al., 1998) . Here evidence is provided that another member of the ephrin family, ephrin-A1, functions during vascular development in vivo.
Ephrin-A1 expression was first detected in mesoderm emerging from the caudal end of the primitive streak and allantoic bud of late gastrulation and head fold stage embryos (7.25 to 7.5 days post-coitum (dpc); Fig. 1A,C) . In mid head fold stage embryos (∼7.5 dpc), ephrin-A1 expression was observed in a crescent of anterior pharyngeal endoderm cells underlying the site of the prospective heart (Fig. 1C) .
In late head fold to 2-somite embryos (∼8.0 dpc), ephrin-A1 expression was observed in the anterior pharyngeal endoderm and presumptive endocardial cells which are located between the presumptive myocardium and underlying endoderm (Fig. 1B,D) . Ephrin-A1 expression was not detected in endothelial cell progenitors of the yolk sac vasculature (Fig. 1D) .
In 8 to 10 somite embryos (∼8.5 dpc), ephrin-A1 transcripts were observed in the endocardium (Fig. 1E,G) , in a developing allantoic vessel (Fig. 1E,H) , and in the dorsal aorta ( Fig. 1E-G) . Interestingly, ephrin-A1 transcripts were also detected in the primary head vein (Fig. 1G) . These data contrast with the recent observation that ephrin-B2 exhibited arterial specific gene expression (Wang et al., 1998) .
At 9.5 to 10.0 dpc, ephrin-A1 expression was observed in the major vessels of the head (e.g. internal carotid artery; Fig. 2A,B) , but the overall level of expression was lower than that observed in 8.5 dpc embryos. In the trunk region, ephrin-A1 was observed in the intersomitic vessels (Fig.  2C ) and the branchial arch arteries (see arrowheads in Fig.  2C,D) . In addition, ephrin-A1 mRNA was detected at the site of front limb bud (Fig. 2C) .
At 10.5 dpc, ephrin-A1 expression was observed in vessel-like structures that appear to branch from the intersomitic vessels (see arrowheads in Fig. 2E ) and in developing limb buds (Fig. 2F) . Interestingly, only a subset of limb bud vessels express ephrin-A1 (Fig. 2G) . In summary, each site of ephrin-A1 expression between 7.5 to 10.5 dpc corresponded to regions of vasculogenesis and/or angiogenesis. In the future, it will be important to identify which eph-A class receptor(s) (Flanagan and Vanderhaeghen, 1998 ) may mediate ephrin-A1 signaling during embryonic vascular development. Previous experiments have not identified an eph-A class receptor expressed in endothelial cells Gale et al., 1996) . Fig. 1 . Ephrin-A1 expression in 7.5 to 8.5 dpc embryos. A 1.3 kb mouse B61 cDNA clone was linearized with BamHI and antisense digoxigenin mRNA probes generated using a digoxigenin RNA labeling kit (Boehringer Mannheim Biochemical) and T7 RNA polymerase. Whole-mount hybridization, sectioning of stained embryos, and photography were carried out as previously described (Ruiz and Robertson, 1994) . (A,C) Lateral view and transverse section, respectively, of a mid head fold stage embryo (plane of section is denoted as an arrowhead in panel A). (B,D) Lateral view and sagittal section, respectively, through the heart-forming region of a 2-somite embryo. (E) Ventral view of a 8-somite embryo. (F-H) Transverse sections of an 8.5 dpc embryo through the trunk region (F), midbrain/heart (G), and caudal neuropore and allantois (H). a, allantois; b, bulbus cordis; bi, blood island; da, dorsal aorta; e, endocardium; en, anterior pharyngeal endoderm; h-r, heart-forming region; m, myocardium; ps, primitive streak; pv, primary head vein; v, ventricle. Bar = 50 mm.
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